Liver Regeneration: Mechanisms, Phases, and Clinical Implications

The liver is the only human solid organ capable of complete functional regeneration after injury or resection. The process restores original mass, architecture, and function.

Key Phases (Post-Partial Hepatectomy Model)

1. Priming (0–6 hrs): Cytokines (TNF-α, IL-6) activate Kupffer cells → NF-κB, STAT3 signaling in hepatocytes → G₀ → G₁ transition.
2. Proliferation (6–72 hrs): Growth factors drive DNA synthesis and mitosis:
   • HGF (hepatocyte growth factor) — primary mitogen via c-Met.
   • EGF, TGF-α — via EGFR.
   • Wnt/β-catenin, Notch, Hippo/YAP pathways.
3. Termination (3–7 days): TGF-β, activin, contact inhibition halt proliferation.
4. Remodelling (weeks–months): Matrix reorganization, biliary/vascular reconstruction, functional maturation.

Cellular Sources

• Mature hepatocytes (primary) — replicate 1–2 times.
• Biliary epithelial cells (cholangiocytes) — ductular reaction; can transdifferentiate.
• Hepatic progenitor cells (oval cells) — activated if hepatocyte proliferation impaired (severe/chronic injury).
• Bone marrow–derived cells — minor contribution.

Angiogenesis and Matrix

• VEGF, angiopoietins drive sinusoidal endothelial proliferation.
• MMPs/TIMPs remodel extracellular matrix.

Factors Impairing Regeneration

• Cirrhosis (architectural disruption, senescence)
• Chronic alcohol, viral hepatitis, NASH
• Severe sepsis, massive necrosis (>70% loss)
• Genetic disorders (α1-antitrypsin, Wilson)
• Malnutrition

Clinical Applications

• Living donor liver transplantation (donor/recipient livers regenerate).
• Resection for tumours (up to 70–75% in healthy liver).
• Acute liver failure support (bridging to recovery/transplant).

Understanding regenerative pathways informs therapies to enhance liver repair and treat chronic liver disease.